Serial Number | 98427253 |
Word Mark | PROJECTSKIN MD |
Filing Date | Thursday, February 29, 2024 |
Status | 641 - NON-FINAL ACTION - MAILED |
Status Date | Monday, September 23, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Description of Mark | The mark consists of the term "PROJECTSKIN" in a stylized font. The letters "MD" in a stylized font are superseded above "PROJECTSKIN". A fanciful image containing seven shapes appears above "PROJECTSKIN". |
Pseudo Mark | PROJECT SKIN MD; PROJECT SKIN DOCTOR OF MEDICINE |
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Goods and Services | Operation of clinics providing dermatology and aesthetic services, namely, dermatology and aesthetic consultations, skincare advices, skin treatments; sale of skincare products; provision of seminars and workshops to skincare professionals in dermatology and aesthetic fields; clinical research in dermatology and aesthetic fields |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, February 29, 2024 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Groupe Dermapure Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Montréal, Québec H3C1V3 CA |
Event Date | Event Description |
Thursday, February 29, 2024 | NEW APPLICATION ENTERED |
Sunday, July 14, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Sunday, July 14, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, September 23, 2024 | NON-FINAL ACTION E-MAILED |
Monday, September 23, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, September 23, 2024 | NON-FINAL ACTION WRITTEN |
Tuesday, September 17, 2024 | ASSIGNED TO EXAMINER |